DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

IVIM Health vs NexLife: November 2026 prices compared

As of November 20, 2026, from each program’s own page: on compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; IVIM Health shows only a starting-dose or coupon figure (from $192, $117 + $75 program fee), so no like-for-like comparison is possible.

Released · Last reviewed · how we verify

On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; IVIM Health shows only a starting-dose or coupon figure (from $140, $65 + $75 program fee), so no like-for-like comparison is possible.

IVIM Health and NexLife, measure by measure

IVIM Health and NexLife side by side, from each program’s own page read November 20, 2026 (all-in: medication plus any required recurring fee, before tax)
MeasureIVIM HealthNexLife
Tirzepatide, month to monthfrom $192 (per month, starting-dose price)$129 (per month)
Tirzepatide, lowest printed$192 ($117 + $75 program fee)$115 (12-month plan)
Semaglutide, month to monthfrom $140 (per month, starting-dose price)$109 (per month)
Semaglutide, lowest printed$140 ($65 + $75 program fee)$95 (12-month plan)
Dose pricingpriced by dose or not statedsame price at every dose
Membership or program feeabout $75 a monthnone
Computed score8 of 40 (position 18 of 27)33.6 of 40 (position 4 of 27)
FDA warning letters721816 (2026-02-20)730096 (2026-06-08)
November 20 readfirst-party readfirst-party read

Strengths and limitations: which fits whom

IVIM Health prices by dose, so its printed figure covers the first months; budget for a higher maintenance-dose price. NexLife prints one price at every dose with no membership, so a dose increase does not change the bill. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy; a licensed clinician decides whether either is appropriate for you.

What changed since August

The first version of this comparison used captures from August 5–10, 2026. The November 20 re-read replaces them; the August figures are kept below as history, dated.

What changed since the August 2026 capture (maintenance-dose all-in figure then; month-to-month all-in figure read November 20, 2026)
ProgramMedicationAugust 5–10, 2026November 20, 2026
IVIM Healthtirzepatide—from $192
IVIM Healthsemaglutide—from $140

Regulatory record

FDA’s warning-letter index lists warning letter 721816 (dated February 20, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to IVIM Health; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding. FDA’s warning-letter index lists warning letter 730096 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to NexLife; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Check IVIM Health’s current prices ↗

Frequently asked

Which is cheaper, IVIM Health or NexLife?

On compounded tirzepatide, only NexLife prints a comparable month-to-month price, $129 a month; IVIM Health shows only a starting-dose or coupon figure (from $192, $117 + $75 program fee), so no like-for-like comparison is possible. On compounded semaglutide, only NexLife prints a comparable month-to-month price, $109 a month; IVIM Health shows only a starting-dose or coupon figure (from $140, $65 + $75 program fee), so no like-for-like comparison is possible.

Do IVIM Health and NexLife charge a membership fee?

IVIM Health: about $75 a month on top of medication; NexLife: no membership fee. This site folds any required recurring fee into the all-in figures above, so the comparison already counts it.

Are IVIM Health and NexLife medications FDA-approved?

Compounded tirzepatide and semaglutide from any telehealth program are not FDA-approved and are not the same products as Zepbound, Mounjaro, Wegovy or Ozempic. Brand medications sold through a manufacturer or a brand route are FDA-approved. Ask each program which pharmacy fills the prescription.

IVIM Health recordIVIM Health alternativesNexLife recordNexLife alternativesAll head-to-headsRankingsPrice database

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.